Stability of the nicotine metabolite ratio in ad libitum and reducing smokers
about
Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioKnown and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersPharmacogenetic Optimization of Smoking Cessation Treatment.Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotineNicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native peopleReproducibility of the nicotine metabolite ratio in cigarette smokers.Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking SmokersHigh dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.Correlates of individual differences in compensatory nicotine self-administration in rats following a decrease in nicotine unit doseNicotine Metabolism in Young Adult Daily Menthol and Nonmenthol SmokersAssociation of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokersNicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation studyStability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes.Utility and relationships of biomarkers of smoking in African-American light smokers.Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence.Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.Variation in CYP2A6 Activity and Personalized Medicine.Characterising the nicotine metabolite ratio and its association with treatment choice: A cross sectional analysis of Stop Smoking Services in England.Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.Nicotine Metabolism in Adults with Type 2 Diabetes.Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
P2860
Q33821233-1ACBF9F4-4357-4433-A1E7-5918BB0131FFQ34135377-1D312CEC-4C96-4138-8117-FDC06DC0AA46Q34542169-8F65B81F-5B11-453B-8ED9-4D6E60BFB0D9Q35099123-CFE8F7EF-6AE5-4C22-832B-F00FD4F39CFDQ35892758-AB432347-B7F6-4C62-B70C-A4A3DA2788D8Q35920608-01F9B310-EE04-4B60-871E-7B3839A01979Q35949266-2EDC1FAE-20DF-46D9-B8F8-2C18E291F949Q36084196-33ACFE01-5842-47F3-9467-DC557B48A8F7Q36303865-3E8E9D18-94AA-46CB-BEF0-7769A21ED46CQ36534993-05F0368C-DE6E-48FE-BC26-74F2EB54AC73Q36696614-BF0883E4-92B6-40A9-8EEF-CBAFEE6BA5B7Q36870991-BA128175-DBE0-4188-805A-84A9481C2B19Q36974499-127ADAD3-E985-451E-9B11-FC14F332959CQ37132295-420DF40F-7000-4C5E-BFBB-42DB89986DBEQ37215518-E8DA9FED-B126-4FB9-A85D-D9DC68CA6F24Q37470700-B8283123-026B-4EE4-A073-DCE972D9071CQ37497939-9A9242F6-B118-48E6-8DC1-58EA7B6A88BCQ37877612-8BA05D31-3181-454E-A06F-BF95AA773AE7Q46297334-C35FF0F3-22B3-457B-ADE2-420C3974C263Q47163198-E5B51D04-783B-4A55-BD91-56B67E9B7919Q47165970-D4F0086D-22E6-4CD1-87BD-6C30973A302AQ47200916-CCDDA192-4EFE-45D4-AF36-8E55ABC8531BQ47741943-1F6AA524-C702-4B6F-8C9C-48A445E196F0Q47742671-A44EEDAD-88E1-4E20-8ED5-753746BB601BQ47804236-C5ED3958-4714-45EC-B1EF-AF198C931D46
P2860
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers
@en
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.
@nl
type
label
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers
@en
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.
@nl
prefLabel
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers
@en
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.
@nl
P2093
P2860
P1476
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers
@en
P2093
Dorothy K Hatsukami
Marc E Mooney
Paul R Pentel
Sharon E Murphy
Zhong-Ze Li
P2860
P304
P356
10.1158/1055-9965.EPI-08-0242
P577
2008-06-01T00:00:00Z